AttendMe Owl Logo
AttendMe
Evidence Evolution
Plastic SurgeryPlastic Surgery

How This Evidence Evolved

Microsurgery for Lymphedema

LVA, VLNT, and the emergence of preventive lymphatic microsurgery

30.5

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Lymphatic surgery has been assessed in small clinical series. A 1988 report operated on 18 patients, with LVA possible in 14; results varied and objective proof of clinical efficacy remained lacking. A later robotic pilot describes supermicrosurgery involving vessels 0.3–0.8 mm in diameter. A LYMPHA report notes that up to 40% of breast cancer patients receiving both axillary dissection and radiotherapy develop lymphedema; this estimate does not apply to all breast cancer survivors. Conservative management with manual drainage, compression and exercise remains a clinical consideration.
Proof

Landmark RCTs and pivotal trials that established the evidence base

In 2000, Koshima and colleagues reported supermicrosurgical lymphaticovenular anastomosis (LVA) for upper-limb lymphedema: with postoperative bandaging, forearm circumference fell by a mean 4.1 cm (47.3% of the preoperative excess) at a mean 2.2 years, vs 0.8 cm (11.7%) after a mean 10.6 months of bandaging alone. Becker reported microsurgical lymph node transplantation from the femoral region to the axilla in 24 women with postmastectomy lymphedema resistant to physiotherapy: the arm perimeter returned to normal in 10 and decreased in 12, with good results especially in early-stage disease. In a prospective series of 100 consecutive lymphovenous bypass cases, indocyanine green (ICG) lymphangiography accurately identified functional lymphatic vessels; mean volume differential reduction at 12 months for upper-extremity lymphedema was 61% in stage 1 or 2 vs 17% in stage 3 or 4, and ICG may have a role in objectively assessing severity and selecting patients.
Extension

Follow-up studies, subgroup analyses, and real-world validation

The LYMPHA (Lymphatic Microsurgical Preventive Healing Approach) technique, described by Boccardo and Campisi in 2009, marked a shift from treatment to prevention. Performed at the time of axillary lymph node dissection (ALND), LYMPHA sutures afferent arm lymphatics into a branch of the axillary vein distal to a competent valve. As many as 40% of breast cancer patients undergoing ALND and radiotherapy develop lymphedema. In a single-institution series, LYMPHA was completed in 27 of 37 attempts; at a mean 6-month follow-up, lymphedema occurred in 12.5% (3/24, described as transient) of completed and 50% (4/8) of unsuccessful cases. ICG lymphography also became a planning tool: in 103 upper limbs with breast cancer-related lymphoedema, the ipsilateral axillary drainage pathway was the most common (67%), and axillary drainage decreased as MD Anderson ICG stage increased.
Now

Current standard of care and ongoing research directions

Reported outcomes differ by technique, stage and measurement. In Chang 2013 LVB series, mean upper-extremity volume differential reduction at 12 months was 61% for stages 1–2 versus 17% for stages 3–4. Becker 2006 LN transplantation reported normal arm perimeter in ten of 24 women and decreased perimeter in twelve. A single-center LYMPHA series completed preventive surgery in 27 of 37 attempted cases, with short follow-up; it does not establish adoption across cancer centers. Outcome measures and follow-up differ across these reports. A randomized pilot compared robot-assisted with manual LVA and reported feasibility at three months; bioengineered lymphatic grafts remain a research question.

Landmark Trials in This Story

Journal of vascular surgery 1988

Microsurgical lymphovenous anastomosis for treatment of lymphedema: a critical review.

At mean 36.6 months after LVA: improvement in 3 upper and 2 lower extremities; 5 unchanged and 4 progressed (single-arm). Objective proof of clinical efficacy remained lacking.

Journal of vascular surgeryClinical case series: 18 operated patients, LVA possible in 14N=18
Chang 2013 LVB series2013

A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.

Mean volume differential reduction at 12 months after lymphovenous bypass: stage 1 or 2 61% vs stage 3 or 4 17% (significantly larger in early stage; overall 42%)

Plast Reconstr SurgProspective consecutive case series of lymphovenous bypass for cancer-related extremity lymphedema (65 with ICG lymphangiography); volumetry before and 3, 6 and 12 months after surgeryN=100
Plast Reconstr Surg 2013

Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes

Reduction rate at mean 39.1 months: groin VLNT 40.4% vs physical therapy 8.3% (p=0.02)

Plast Reconstr SurgComparative clinical and cadaveric study
Koshima 2000 LVA2000

Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities.

Forearm circumference decrease: LVA plus bandaging 4.1 cm (47.3% of preoperative excess) at mean 2.2 years vs bandaging alone 0.8 cm (11.7%) at mean 10.6 months (no p value reported)

J Reconstr MicrosurgComparative case series over 8 years in women with unilateral upper-limb obstructive lymphedema: LVA with postoperative bandaging (12) vs continual bandaging alone (12)N=27
Becker 2006 LN transplantation2006

Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation.

Upper limb perimeter after lymph node transplantation (24 women): normal in 10, decreased in 12, unchanged in 2; physiotherapy stopped in 15 (62.5%) (no comparator)

Ann SurgCase series: femoral-region lymph nodes transplanted to the axilla in women with postmastectomy lymphedema for more than 5 years, resistant to physiotherapyN=24
LYMPHA2015Landmark

Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema

Lymphedema at mean 6 months: completed LYMPHA 12.5% (3/24) vs unsuccessful attempt 50% (4/8)

Annals of surgical oncologyCohortN=37
BMC cancer 2019

A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema

Ipsilateral axillary drainage on ICG lymphography: 67% of 103 upper limbs with BCRL (single-arm study)

BMC cancerProspective imaging protocol study
Nature communications 2020

First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial.

Patient outcomes at 1 and 3 months, surgery duration and anastomosis quality; robot-assisted anastomosis duration declined from 33 to 16 minutes. Pilot feasibility report, not proof of broad superiority.

Nature communicationsProspective randomized pilot of robot-assisted versus manual LVA for breast-cancer-related lymphedema

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Frequently Asked Questions

What is the difference between LVA and VLNT?+
Lymphovenous anastomosis (LVA) creates direct microscopic connections between lymphatic channels and venules, bypassing obstructed lymphatics. It works best in early-stage disease: in 100 consecutive bypass cases, mean upper-extremity volume differential reduction at 12 months was 61% in stage 1 or 2 vs 17% in stage 3 or 4. Vascularized lymph node transfer (VLNT) transplants lymph node-containing tissue flaps to restore drainage capacity; in a groin-flap series, the reduction rate at a mean 39.1 months was 40.4% vs 8.3% with physical therapy (p=0.02).
Can lymphedema be prevented surgically?+
The LYMPHA technique, performed at the time of axillary lymph node dissection, creates prophylactic lymphovenous connections. As many as 40% of breast cancer patients undergoing axillary dissection and radiotherapy develop lymphedema. In a single-institution series, the lymphedema rate at a mean 6-month follow-up was 12.5% (3/24) after completed LYMPHA vs 50% (4/8) after unsuccessful attempts; the authors call it feasible, safe and effective on early data.
How is ICG lymphography used in lymphedema management?+
ICG lymphography maps lymphatic drainage and can identify functional lymphatic vessels. In a prospective bypass series, it accurately identified vessels and might help assess severity and select patients. A separate protocol assessed 103 upper limbs with breast-cancer-related lymphoedema: ipsilateral axillary drainage occurred in 67% and decreased as MDACC stage increased. These studies do not establish every technical protocol, intraoperative-patency or serial-response claim.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026